What is NDC 62135-876?

62135-876 is the product NDC for Bupropion Hydrochloride (XL), Bupropion hydrochloride 300 mg/1 tablet, extended release, listed with the FDA by Chartwell RX, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Chartwell RX, LLC, NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bupropion Hydrochloride (XL)?

72 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Bupropion Hydrochloride (XL) NDC 62135-876

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-876Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0876Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-876-30	62135087630	30 TABLET, EXTENDED RELEASE in 1 PACKAGE (62135-876-30)Marketed from Mar 28, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bupropion Hydrochloride (XL)
Generic name (nonproprietary): bupropion hydrochloride (xl)
Active ingredients: Bupropion hydrochloride — 300 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Chartwell RX, LLCNDC labeler code 62135
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208652
Marketing start: Aug 21, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Dopamine Uptake Inhibitors (Mechanism)Increased Dopamine Activity (Physiologic effect)Increased Norepinephrine Activity (Physiologic effect)Norepinephrine Uptake Inhibitors (Mechanism)
Identifiers: Product ID 62135-876_155edd5e-1f89-6a6c-e063-6394a90aacddSPL ID 155edd5e-1f89-6a6c-e063-6394a90aacddSPL set ID 8d9779e7-300e-4720-8ba5-2272b2506cd9RxCUI 993541, 993557UNII ZG7E5POY8OUPC 0362135876302, 0362135875305
Pharmacologic class: Aminoketone

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135087630 followed by a unit qualifier and the quantity

Package 62135-0876-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 5, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Bupropion hydrochloride extended-release tablets (XL) is an aminoketone antidepressant, indicated for: treatment of major depressive disorder (MDD) ( 1.1 ) prevention of seasonal affective disorder (SAD) ( 1.2 ) 1.1 Major Depressive Disorder (MDD) Bupropion hydrochloride extended-release tablets (XL) are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM). The efficacy of the immediate-release formulation of bupropion was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult patients with MDD. The efficacy of the sustained-release formulation of bupropion in the maintenan…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62135-876

What is NDC 62135-876?: 62135-876 is the product NDC for Bupropion Hydrochloride (XL), Bupropion hydrochloride 300 mg/1 tablet, extended release, listed with the FDA by Chartwell RX, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bupropion Hydrochloride (XL).
What is the active ingredient?: Bupropion hydrochloride.
Who is the labeler?: Chartwell RX, LLC, NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bupropion Hydrochloride (XL)?: 72 other product NDCs are listed under this name. See all Bupropion Hydrochloride (XL) NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Bupropion Hydrochloride (XL) NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Bupropion Hydrochloride (XL)bupropion hydrochloride	Bupropion hydrochloride 300 mg/1	Tablet, Film coated, Extended releaseOral	Preferred Pharmaceuticals Inc.	68788-4172	68788-4172-0168788-4172-0368788-4172-06+2 more
Bupropion Hydrochloride XLbupropion hydrochloride	Bupropion hydrochloride 150 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-0699	67046-0699-03
Bupropion Hydrochloride (XL)bupropion hydrochloride	Bupropion hydrochloride 150 mg/1	Tablet, Film coated, Extended releaseOral	Northwind Health Company, LLC	82868-097	82868-0097-96
Bupropion Hydrochloride (XL)bupropion hydrochloride	Bupropion hydrochloride 300 mg/1	Tablet, Film coated, Extended releaseOral	Advanced Rx of Tennessee, LLC	80425-0539	80425-0539-0180425-0539-0280425-0539-03
Bupropion Hydrochloride XLbupropion hydrochloride	Bupropion hydrochloride 300 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4446	70518-4446-00
Bupropion Hydrochloride XLbupropion hydrochloride	Bupropion hydrochloride 300 mg/1	Tablet, Extended releaseOral	Advanced Rx of Tennessee, LLC	80425-0468	80425-0468-0180425-0468-0280425-0468-03
Bupropion Hydrochloride XLbupropion hydrochloride	Bupropion hydrochloride 150 mg/1	Tablet, Extended releaseOral	Major Pharmaceuticals	0904-7505	00904-7505-0400904-7505-61
Bupropion Hydrochloride XLbupropion hydrochloride	Bupropion hydrochloride 300 mg/1	Tablet, Extended releaseOral	Major Pharmaceuticals	0904-7469	00904-7469-04
Bupropion Hydrochloride (XL)bupropion hydrochloride	Bupropion hydrochloride 150 mg/1	Tablet, Film coated, Extended releaseOral	Quality Care Products, LLC	83008-082	83008-0082-30
Bupropion Hydrochloride (XL)bupropion hydrochloride	Bupropion hydrochloride 150 mg/1	Tablet, Extended releaseOral	Mullan Pharmaceutical Inc.	83301-0024	83301-0024-0183301-0024-0283301-0024-03+1 more

All 73 Bupropion Hydrochloride (XL) NDCs

Other NDCs under ANDA 208652

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208652
Product	Strength	Form · route	Labeler	Product NDC
Bupropion hydrochloride (XL)bupropion hydrochloride	Bupropion hydrochloride 150 mg/1	Tablet, Extended releaseOral	Vitruvias Therapeutics	69680-157
Bupropion Hydrochloride (XL)bupropion hydrochloride	Bupropion hydrochloride 150 mg/1	Tablet, Extended releaseOral	Mullan Pharmaceutical Inc.	83301-0024
Bupropion Hydrochloride (XL)bupropion hydrochloride	Bupropion hydrochloride 300 mg/1	Tablet, Extended releaseOral	Mullan Pharmaceutical Inc.	83301-0025
Bupropion hydrochloride (XL)bupropion hydrochloride	Bupropion hydrochloride 150 mg/1	Tablet, Extended releaseOral	Lannett Company Inc.	0527-2415
Bupropion Hydrochloride (XL)	Bupropion hydrochloride 150 mg/1	Tablet, Extended releaseOral	Chartwell RX, LLC	62135-875
Bupropion hydrochloride (XL)bupropion hydrochloride	Bupropion hydrochloride 300 mg/1	Tablet, Extended releaseOral	Vitruvias Therapeutics	69680-158
Bupropion hydrochloride (XL)bupropion hydrochloride	Bupropion hydrochloride 300 mg/1	Tablet, Extended releaseOral	Lannett Company Inc.	0527-2430